1. Home
  2. ARW vs ABVX Comparison

ARW vs ABVX Comparison

Compare ARW & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARW
  • ABVX
  • Stock Information
  • Founded
  • ARW 1935
  • ABVX 2013
  • Country
  • ARW United States
  • ABVX France
  • Employees
  • ARW N/A
  • ABVX N/A
  • Industry
  • ARW Electronic Components
  • ABVX
  • Sector
  • ARW Technology
  • ABVX
  • Exchange
  • ARW Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • ARW 6.7B
  • ABVX 6.7B
  • IPO Year
  • ARW N/A
  • ABVX N/A
  • Fundamental
  • Price
  • ARW $117.62
  • ABVX $100.77
  • Analyst Decision
  • ARW Hold
  • ABVX Strong Buy
  • Analyst Count
  • ARW 4
  • ABVX 10
  • Target Price
  • ARW $115.75
  • ABVX $103.80
  • AVG Volume (30 Days)
  • ARW 563.4K
  • ABVX 1.1M
  • Earning Date
  • ARW 10-30-2025
  • ABVX 08-11-2025
  • Dividend Yield
  • ARW N/A
  • ABVX N/A
  • EPS Growth
  • ARW N/A
  • ABVX N/A
  • EPS
  • ARW 8.85
  • ABVX N/A
  • Revenue
  • ARW $28,500,160,000.00
  • ABVX $7,073,400.00
  • Revenue This Year
  • ARW $10.15
  • ABVX $4.44
  • Revenue Next Year
  • ARW $6.03
  • ABVX N/A
  • P/E Ratio
  • ARW $13.13
  • ABVX N/A
  • Revenue Growth
  • ARW N/A
  • ABVX N/A
  • 52 Week Low
  • ARW $86.50
  • ABVX $4.77
  • 52 Week High
  • ARW $137.80
  • ABVX $98.94
  • Technical
  • Relative Strength Index (RSI)
  • ARW 44.22
  • ABVX 74.51
  • Support Level
  • ARW $115.76
  • ABVX $90.85
  • Resistance Level
  • ARW $123.02
  • ABVX $94.26
  • Average True Range (ATR)
  • ARW 3.05
  • ABVX 3.46
  • MACD
  • ARW -0.09
  • ABVX 0.17
  • Stochastic Oscillator
  • ARW 38.00
  • ABVX 96.24

About ARW Arrow Electronics Inc.

Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: